Scinai Immunotherapeutics Ltd. (SCNI) NASDAQ
0.74
+0.2887(+63.31%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.66M |
| Enterprise Value | 2.27M |
| P/E Ratio | -0.2 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.76 |
| Price/Book Ratio | 0.22 |
| Enterprise/Revenue | 1.22 |
| Enterprise/EBITDA | -0.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -6.73 |
| Operating Margin | -5.75 |
Management Effectiveness
| Return On Assets | -0.76 |
| Return On Equity | -1.04 |
Income Statement
| Revenue | 1.31M |
| Revenue/Share | 0.56 |
| Gross Profit | -2.65M |
| EBITDA | -6.53M |
| Net Income | -8.31M |
| Diluted EPS | -3.6 |
Balance Sheet
| Total Cash | 1.66M |
| Total Cash/Share | 0.71 |
| Total Debt | 2.27M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 1.3 |
| Book Value Per Share | 3.47 |
Price History
| 52-Week Change | -69.57 |
| 52-Week High | 6.18 |
| 52-Week Low | 0.46 |
| Moving Average 50 Days | 0.69 |
| Moving Average 200 Days | 1.16 |
Statistics
| Average Volume | 51,643 |
| Shares Outstanding | 1.32M |
| % Held by Institutions | 8.09 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | May 21, 2024 |
